Boehringer Ingelheim to acquire NBE-Therapeutics for €1.1bn

Boehringer Ingelheim has entered into a transformative €1.18 billion agreement to acquire NBE-Therapeutics, a clinical-stage biotech company based in Switzerland. This strategic acquisition is set ... Read More